Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance
April 25, 2024 4:49 AM EDTSanofi (NASDAQ: SNY) reported Q1 EPS of EUR1.78, EUR0.85 better than the analyst estimate of EUR0.93. Revenue for the quarter came in at EUR10.46 billion versus the consensus estimate of EUR11.47 billion.
GUIDANCE
Sanofi expects 2024 business EPS to remain roughly... More
